First in class drug in fight against Sepsis
Scientists at Queen’s University Belfast have developed a revolutionary new first-in-class treatment for sepsis and the Acute Respiratory Distress Syndrome (ARDS).
The novel anti-inflammatory drug has been developed by a team of scientists and clinicians at the School of Pharmacy and the Centre for Infection and Immunity at Queen’s, alongside colleagues at Trinity College Dublin (TCD).
Queen's University Belfast is committed to Equality, Diversity and Inclusion.
For more information please read our Equality and Diversity Policy.
Queen's University Belfast is registered with the Charity Commission for Northern Ireland NIC101788
VAT registration number: GB 254 7995 11